Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Richard Keon
Introduction
Richard Keon is a notable inventor based in Calgary, Canada. He has made significant strides in the field of biotechnology, particularly in the production of insulin through innovative methods. His work has the potential to revolutionize how insulin is produced and distributed.
Latest Patents
Richard Keon holds a patent for "Methods for the production of insulin in plants." This groundbreaking patent outlines a method for the commercial production of human insulin via transgenic expression in plant seeds. The process allows for insulin accumulation levels exceeding 0.1% of total cellular protein, achieved through the expression of insulin with a single-chain antibody as a fusion partner. The production in seeds offers advantages in storage and shipment, as insulin retains its activity upon extraction from stored seeds. Additionally, the low water content of plant seeds limits the amount of biomass needed for extraction.
Career Highlights
Richard Keon is associated with Sembiosys Genetics, Inc., where he continues to develop and refine his innovative approaches to biotechnology. His work has garnered attention for its potential applications in the medical field, particularly for diabetes management.
Collaborations
Richard has collaborated with notable colleagues such as Maurice M Moloney and Joseph Boothe. Their combined expertise contributes to the advancement of biotechnological innovations.
Conclusion
Richard Keon's contributions to the field of biotechnology, particularly in insulin production, highlight the importance of innovation in addressing medical needs. His work exemplifies how scientific advancements can lead to practical solutions for global health challenges.